UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis

Circulation research, 2019-02, Vol.124 (3), p.437-450

Ridker, Paul M

2019

Volltextzugriff (PDF)

A Test in Context: High-Sensitivity C-Reactive Protein

Journal of the American College of Cardiology, 2016-02, Vol.67 (6), p.712-723

Ridker, Paul M

2016

Volltextzugriff (PDF)

Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin

European heart journal, 2016-06, Vol.37 (22), p.1720-1722

Ridker, Paul M

2016

Volltextzugriff (PDF)

Should Aspirin Be Used for Primary Prevention in the Post-Statin Era?

The New England journal of medicine, 2018-10, Vol.379 (16), p.1572-1574

Ridker, Paul M

2018

Volltextzugriff (PDF)

LDL cholesterol: controversies and future therapeutic directions

The Lancet (British edition), 2014-08, Vol.384 (9943), p.607-617

Ridker, Paul M, Dr Prof

2014

Volltextzugriff (PDF)

C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: Moving an inflammatory hypothesis toward consensus

Journal of the American College of Cardiology, 2007-05, Vol.49 (21), p.2129-2141

RIDKER, Paul M

2007

Volltextzugriff (PDF)

Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis

European heart journal, 2020-06, Vol.41 (23), p.2153-2163

2020

Volltextzugriff (PDF)

Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents

European heart journal, 2016-05, Vol.37 (17), p.1373-1379

2016

Volltextzugriff (PDF)

A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians

PloS one, 2015-04, Vol.10 (4), p.e0120758-e0120758

2015

Volltextzugriff (PDF)

Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease

The New England journal of medicine, 2016-12, Vol.375 (24), p.2349-2358

2016

Volltextzugriff (PDF)

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

The Lancet (British edition), 2012-08, Vol.380 (9841), p.565-571

2012

Volltextzugriff (PDF)

Statins: new American guidelines for prevention of cardiovascular disease

The Lancet (British edition), 2013-11, Vol.382 (9907), p.1762-1765

2013

Volltextzugriff (PDF)

Autoimmune diseases and atherothrombotic risk

The Lancet (British edition), 2022-09, Vol.400 (10354), p.708-710

Ridker, Paul M

2022

Volltextzugriff (PDF)

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

Circulation (New York, N.Y.), 2003-01, Vol.107 (3), p.363-369

RIDKER, Paul M

2003

Volltextzugriff (PDF)

Mortality Differences Associated With Treatment Responses in CANTOS and FOURIER: Insights and Implications

Circulation (New York, N.Y.), 2018-04, Vol.137 (17), p.1763-1766

Ridker, Paul M

2018

Volltextzugriff (PDF)

Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease

Journal of the American College of Cardiology, 2020-05, Vol.75 (17), p.2122-2135

2020

Volltextzugriff (PDF)

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

The American heart journal, 2011-10, Vol.162 (4), p.597-605

2011

Volltextzugriff (PDF)

Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality: Implications for Longevity

Nutrition reviews, 2007-12, Vol.65 (12), p.253-259

Ridker, Paul M

2007

Volltextzugriff (PDF)

Proteomics for the prediction and prevention of atherosclerotic disease

European heart journal, 2022-04, Vol.43 (16), p.1578-1581

Ridker, Paul M

2022

Volltextzugriff (PDF)

Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures

Annals of internal medicine, 2009-06, Vol.150 (11), p.795

2009

Volltextzugriff (PDF)

Low-dose colchicine for chronic stable atherosclerosis: Under-appreciated and under-prescribed

European journal of internal medicine, 2024-07, Vol.125, p.36-38

Ridker, Paul M

2024

Volltextzugriff (PDF)

Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women

Circulation. Genomic and precision medicine, 2018-04, Vol.11 (4), p.e002157-e002157

2018

Volltextzugriff (PDF)

Lipoprotein(a) and Cardiovascular Risk Prediction Among Women

Journal of the American College of Cardiology, 2018-07, Vol.72 (3), p.287-296

2018

Volltextzugriff (PDF)

Calibration of the Pooled Cohort Equations for Atherosclerotic Cardiovascular Disease: An Update

Annals of internal medicine, 2016-12, Vol.165 (11), p.786

2016

Volltextzugriff (PDF)

High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy

Circulation (New York, N.Y.), 2013-09, Vol.128 (11), p.1189-1197

2013

Volltextzugriff (PDF)

1 – 25 von 1.159

Suche als RSS-Feed

Aktive Filter

ThemaInflammation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.106)
Mit Volltextzugriff
(939)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.159)
Japanisch
(203)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(709)
Science & Technology
(709)
Life Sciences & Biomedicine
(690)
Female
(412)
Middle Aged
(366)
Risk Factors
(365)
Biological And Medical Sciences
(335)
Cardiovascular System & Cardiology
(335)
Medical Sciences
(328)
Male
(297)
Cardiac & Cardiovascular Systems
(285)
Aged
(243)
Cardiology. Vascular System
(189)
Cardiovascular Disease
(183)
Prospective Studies
(172)
General & Internal Medicine
(152)
Medicine, General & Internal
(152)
Peripheral Vascular Disease
(147)
Adult
(145)
Cholesterol
(114)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)
... seit 30 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis

A Test in Context: High-Sensitivity C-Reactive Protein

Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin

Should Aspirin Be Used for Primary Prevention in the Post-Statin Era?

LDL cholesterol: controversies and future therapeutic directions

C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: Moving an inflammatory hypothesis toward consensus

Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis

Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents

A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians

Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

Statins: new American guidelines for prevention of cardiovascular disease

Autoimmune diseases and atherothrombotic risk

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

Mortality Differences Associated With Treatment Responses in CANTOS and FOURIER: Insights and Implications

Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality: Implications for Longevity

Proteomics for the prediction and prevention of atherosclerotic disease

Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures

Low-dose colchicine for chronic stable atherosclerosis: Under-appreciated and under-prescribed

Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women

Lipoprotein(a) and Cardiovascular Risk Prediction Among Women

Calibration of the Pooled Cohort Equations for Atherosclerotic Cardiovascular Disease: An Update

High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy

Aktive Filter

Suchergebnisse filtern